Verified email-pattern data for Quadvantage Technologies, Inc. is currently limited. You can still use the company insights and contact sections below.
Improving ACL Reconstruction with a Better Quadriceps Tendon Autograft Medical Device
Company Details
- Founded
- -
- Address
- 3801 Wake Forest Road,
- Industry
- Medical Equipment Manufacturing
- Website
- http://www.QuadVantage.com
- Keywords
- Orthopaedic Surgery.
- HQ
- RALEIGH, NC
Quadvantage Technologies, Inc. Questions
QuadVantage Technologies, Inc.'s website is http://www.QuadVantage.com
QuadVantage Technologies, Inc.'s LinkedIn profile is https://www.linkedin.com/company/quadvantage-technologies-inc
QuadVantage Technologies, Inc.'s industry is
Medical Equipment Manufacturing
QuadVantage Technologies, Inc.'s top competitors are
Novopedics, Inc.,
Cardinal Health,
Ao Research Institute Davos (Ari),
Quadvantage, Inc,
Laerdal Medical,
Zimmer Biomet.
QuadVantage Technologies, Inc.'s categories are Medical Equipment Manufacturing
QuadVantage Technologies, Inc.'s founding year is 2018
Explore related pages
Related company profiles:
Companies like QuadVantage Technologies, Inc.
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.